Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation
about
The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationSAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinomaHow is Indonesia coping with its epidemic of chronic noncommunicable diseases? A systematic review with meta-analysis.Current status of cancer care for young patients with nasopharyngeal carcinoma in Jakarta, Indonesia.Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imagingRole of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population.Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinomaPrimary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma.Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic ImpactWNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.Effectiveness of a multicentre nasopharyngeal carcinoma awareness programme in Indonesia.The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective StudyIncidence Trends and Geographical Distribution of Nasopharyngeal Carcinoma in Iran.Rad51 Expression in Nasopharyngeal Carcinoma and Its Association with Tumor Reduction: A Preliminary Study in Indonesia.Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor originIdentification and analysis of the promoter region of the STGC3 gene.Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy.Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis.Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma.Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1Pre-treatment serum inflammatory cytokines as survival predictors of patients with nasopharyngeal carcinoma receiving chemoradiotherapy.Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axisAn inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinomaEpstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions.Trends in the epidemiology of head and neck cancer in London.Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.The 656C and 725C are two important sites in gene STGC3 for its negative regulation on cell growthCo-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
P2860
Q26853527-B162946B-8F23-4FD9-A1E4-0EAF2C8A2033Q28235586-27FE54BC-6C44-42D9-A95F-D795B12316D7Q33817318-A610AB79-A8CE-4F1A-AD94-BD4109FDB82CQ33896645-4F36D5A0-7983-4E21-8360-4B92C9007382Q33953134-BD764FDC-AE09-4F8E-AB9A-A2E905116967Q34174371-BCF833B7-ACCD-4B8F-AD27-93169995A4BAQ34286259-E4CC09EC-5EB2-423D-9CB4-7BCD80344FDEQ34526425-5DBD6554-5B8B-48A7-835F-27BFBF3460F6Q34722985-544A2B21-F4B2-4B55-AF49-B7DD5DCBE96BQ35207555-CA0AD019-AA02-4047-A318-F1DE842160F4Q35640038-BD78461A-8986-4D0B-B0ED-E9C1FC3A2430Q35763706-FFAC5117-74A6-4DF2-A04F-804350C7671CQ35832964-E2A949AD-6C0A-458D-989C-C24F67F78B54Q35942119-3D954E3A-5DB6-4E22-94CD-8AC510BEB260Q35974884-54C26D29-9B96-4B28-A065-2191784830BBQ36064972-23EA09BB-C49E-4F08-9573-2DFC9115E891Q36097164-E29B61BB-66C4-4565-B4BC-1C76A0D4389FQ36121167-EF5E9565-98FB-4131-88ED-EAE2E0F0CAC1Q36124331-B3E5A38B-DF90-4381-BDD4-9B55E70BB3DAQ36220615-F33A0125-3635-43BF-BDB4-03A75DC9ECA3Q36291469-633F1EE6-D139-4A2D-9867-47B670D2F32BQ36382531-7DEE83C9-3FBF-42DF-AB75-0D3164C14A34Q36940726-BA09BA46-72F4-42C5-ADAE-8FD3FBBAFF56Q37075824-D9711B20-FEF9-49E9-85B5-2B87326616CAQ37227757-774A6FE6-6365-436E-A4BF-B7048A9CFBCCQ37353950-C2B9B7E2-E315-4F8F-B000-995FE8CB8D7BQ37362680-2DA925CE-514B-4DCD-BD3C-99F5DD773329Q37376186-F073A833-489D-4B11-BEB7-170C9D819AD0Q37417939-C933AAA4-5533-4D61-B99F-713CE7D5B7B6Q37582160-FEE90095-630A-49DC-AA91-B2D39AA55785Q37603302-0B74303C-0143-47EE-B64B-CEE12F1D23C4Q37609486-EC39004C-4839-4788-9E57-59C30FAC0817Q37621102-B640A26B-DEC8-416D-BA37-958A119D1679Q38862254-CA699BEB-07C6-46E9-94FD-B857AC8CE3A2Q38865662-690AF882-0F4E-47C6-B427-E40CBF883356Q39761930-ED8F1FF6-DCBC-4D3E-AC59-98F2A8FDFDD0Q40085909-92DA8BFA-0743-4E43-A57C-2D5C4B4E26D9Q40324400-9CBD5741-B653-4BD8-BD1A-D7FC29268E1CQ40742844-169CC09F-EC8A-4960-BB64-71C97AF31C33Q41165122-E900053C-A179-4D1D-ACE9-0C1FA00F2BD1
P2860
Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@ast
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@en
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@nl
type
label
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@ast
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@en
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@nl
prefLabel
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@ast
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@en
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@nl
P2093
P2860
P3181
P356
P1476
Nasopharyngeal carcinoma in In ...... , and symptoms at presentation
@en
P2093
Antonius N Kurniawan
Arina Ika Muhtadi
Averdi Roezin
Bambang Hermani
I Bing Tan
Jaap M Middeldorp
Marlinda Adham
Soehartati Gondhowiardjo
P2860
P304
P3181
P356
10.5732/CJC.011.10328
P407
P577
2012-04-01T00:00:00Z